Volume 18, Issue 2 (7-2021)                   J Res Dev Nurs Midw 2021, 18(2): 36-40 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Afolalu O O, Atekoja O E, Akingbade O, Jolayemi K I, Oyewumi Z O, Oyelabi B D et al . Knowledge and Perceived Effect of Polypharmacy and Potentially Inappropriate Medication Use among Nurses in a Nigerian Tertiary Hospital. J Res Dev Nurs Midw. 2021; 18 (2) :36-40
URL: http://nmj.goums.ac.ir/article-1-1318-en.html
1- Department of Nursing Science, Osun State University, Nigeria , olamide.afolalu@uniosun.edu.ng
2- Department of Nursing Science, Olabisi Onabanjo University, Ogun State, Nigeria
3- The Nethersole School of Nursing, Chinese University of Hong Kong, China
4- Department of Nursing Science, Adeleke University, Osun State, Nigeria
5- Department of Nursing Science, Achievers University, Ondo State, Nigeria
6- Department of Nursing Science, Osun State University Osogbo, Osun State, Nigeria
7- Department of Nursing Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
Abstract:   (212 Views)
Background: Polypharmacy (PP) and inappropriate medication use (IMU) are issues that negatively affect the health care system. Despite nurses’ engagement and important role in prevention of drug-related issues, awareness regarding consequences of PP and IMU is relatively low. This study aimed to determine the knowledge and perception effects about PP and IMU among nurses in the Lautech teaching hospital, Osun state, Nigeria.
Methods: This descriptive, cross-sectional study was performed on 190 randomly selected nurses working at the Lautech teaching hospital (Osun state, Nigeria) in June 2020. Data were collected using a researcher-made questionnaire. The reliability of the questionnaire was verified by obtaining a Cronbach alpha score of 0.77. Data analysis was done in SPSS 25 using descriptive statistics, the Chi-square test. All analyses were carried out at significance level of 0.05.
Results: The findings revealed that most nurses (84.2%) had good knowledge about PP. In addition, 93.2% of the nurses claimed that IMU should be entirely avoided. According to the nurses, the most important perceived effect of PP and IMU was adverse drug reactions (57.9%). There was a significant relationship between nurses level of educational and knowledge of PP (χ2=12.095, P=0.002). Moreover, there was a positive correlation between the respondents’ age and knowledge of PP (r=0.204, P=0.016). There was also a significant negative correlation between the nurses' knowledge and perceived effect of PP and IMU (r=0.605, P<0.001).
Conclusion: The results indicate that the nurses working at the study setting possess good knowledge of PP and IMU. Educational programs such as seminars and workshops are essential for translating this information into routine nursing care.
Full-Text [PDF 862 kb]   (70 Downloads) |   |   Full-Text (HTML)  (34 Views)  
Type of Study: Original Article | Subject: Nursing

References
1. World Health Organization. Medication safety in polypharmacy. Geneva: World Health Organization, 2019.
2. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017; 17(1):1-0. [View at paplisher] [DOI] [PMID] [Google Scholar]
3. Khan N, Chattopadhyay K, Leonardi-Bee J. Incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia: a systematic review protocol. JBI Evidence Synthesis. 2019; 17(11):2370-7. [View at paplisher] [DOI] [PMID] [Google Scholar]
4. Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety. 2020 [View at paplisher] [DOI] [PMID] [Google Scholar]
5. Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Scientific Data. 2017; 4(1):1-11. [View at paplisher] [DOI] [PMID] [Google Scholar]
6. Akande-Sholabi W, Adebusoye L, Olowookere O. Polypharmacy and factors associated with their prevalence among older patients attending a geriatric centre in South-West Nigeria. West African Journal of Pharmacy. 2018; 29(1):35- 45. [View at paplisher] [DOI] [Google Scholar]
7. Gbeasor-Komlanvi FA, Zida-Compaore WI, Dare IH, Diallo A, Darre TP, Potchoo Y, et al. Medication Consumption Patterns and Polypharmacy among Community-Dwelling Elderly in Lomé (Togo) in 2017. Current Gerontology and Geriatrics Research.2020. [View at paplisher] [DOI] [PMID] [Google Scholar]
8. Ssonko M, Stanaway F, Mayanja HK, Namuleme T, Cumming R, Kyalimpa JL, et al. Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda. BMC Geriatrics. 2018; 18(1):1-8. [View at paplisher] [DOI] [PMID] [Google Scholar]
9. Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016; 7(1):11-22. [View at paplisher] [DOI] [PMID] [Google Scholar]
10. Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: a systematic review and meta-analysis. Journal of the American Pharmacists Association. 2017; 57(6):729-38. [View at paplisher] [DOI] [PMID] [Google Scholar]
11. Sun W, Lam A. Raising awareness about the critical importance of the nursing role in deprescribing medication for older adults. Perspectives. 2019; 40(4):17-22. [View at paplisher] [Google Scholar]
12. Djerbib A. A qualitative systematic review of the factors that influence prescribing decisions by nurse independent prescribers in primary care. Primary Health Care. 2018; 28(3):25. [View at paplisher] [DOI] [Google Scholar]
13. Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Research in Social and Administrative Pharmacy. 2018; 14(1):18-25. [View at paplisher] [DOI] [PMID] [Google Scholar]
14. Mecca MC, Thomas JM, Niehoff KM, Hyson A, Jeffery SM, Sellinger J, et al. Assessing an interprofessional polypharmacy and deprescribing educational intervention for primary care post-graduate trainees: a quantitative and qualitative evaluation. Journal of General Internal Medicine. 2019; 34(7):1220-7. [View at paplisher] [DOI] [PMID] [Google Scholar]
15. Campins L, Serra-Prat M, Gózalo I, López D, Palomera E, Agustí C, et al. Randomized controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people. Family Practice. 2017; 34(1):36-42. [View at paplisher] [DOI] [PMID] [Google Scholar]
16. Sun W, Tahsin F, Abbass Dick J, Barakat C, Turner J, Wilson D, et al. Educating Homecare Nurses about Deprescribing of Medications to Manage Polypharmacy for Older Adults. Western Journal of Nursing Research. 2021. [View at paplisher] [DOI] [PMID] [Google Scholar]
17. Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opinion on Drug Safety. 2018; 17(12):1185-96. [View at paplisher] [DOI] [PMID] [Google Scholar]
18. Engel RJ, Schutt RK. The practice of research in social work. Sage Publications; 2016.
19. Brown JD. The Cronbach alpha reliability estimate. Jalt Testing & Evaluation Sig Newsletter. 2002; 6(1). [View at paplisher] [Google Scholar]
20. Fadare JO, Obimakinde AM, Enwere OO, Desalu OO, Ibidapo RO. Physician's Knowledge of Appropriate Prescribing for the Elderly-A Survey Among Family and Internal Medicine Physicians in Nigeria. Frontiers in Pharmacology. 2019; 10:592. [View at paplisher] [DOI] [PMID] [Google Scholar]
21. Bell HT, Granas A, Enmarker I, Omli R, Steinsbekk A. Nurses' and pharmacists' learning experiences from participating in interprofessional medication reviews for elderly in primary health care-a qualitative study. BMC Family Practice. 2017; 18(1):1-9. [View at paplisher] [DOI] [PMID] [Google Scholar]
22. Huisman BA, Geijteman EC, Dees MK, Schonewille NN, Wieles M, van Zuylen L, et al. Role of nurses in medication management at the end of life: a qualitative interview study. BMC Palliative Care. 2020; 19:1-11. [View at paplisher] [DOI] [PMID] [Google Scholar]
23. Badawy NA, Labeeb SA, Alsamdan MF, Alazemi BF. Prevalence and Risk of Polypharmacy among Community-Dwelling, Elderly Kuwaiti Patients. Medical Principles and Practice. 2020; 29(2):166-73. [View at paplisher] [DOI] [PMID] [Google Scholar]
24. Varghese D, Ishida C, Haseer Koya H. Polypharmacy. [Updated 2021 Jul 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532953/
25. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. Drug Safety. 2007; 30(10):911-8. [View at paplisher] [DOI] [PMID] [Google Scholar]
26. Valenza PL, McGinley TC, Feldman J, Patel P, Cornejo K, Liang N, Anmolsingh R, McNaughton N. Dangers of polypharmacy. InVignettes in Patient Safety-Volume 1 2017 Sep 13. IntechOpen. [View at paplisher] [DOI]
27. Schenker Y, Park SY, Jeong K, Pruskowski J, Kavalieratos D, Resick J, et al. Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness. Journal of General Internal Medicine. 2019; 34(4):559-66. [View at paplisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Research Development in Nursing and Midwifery

Designed & Developed by : Yektaweb